Trazodona combinada con ISRS e ISRN en pacientes deprimidos que presentan ansiedad e insomnio

In depressed patients with residual sleep disorders treated with SSRIs or SNRIs, the addition of TZD improved depression, insomnia and anxiety. These benefits were accompanied by an improved emotional state and vitality that positively influenced the patients' quality of life. However, studies involving a larger number of patients that could contribute stratified data are required. For the time being, the available information suggests that the above-mentioned drug combinations are beneficial.